Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Nutranomics, Inc.
DRAPER, Utah, Jan. 29, 2014 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to provide this follow-up press release to highlight the Company's on-going expansion strategy with business partner UNO International Corp ("UNO"), a leading health and natural products distributor and the largest multi-level marketing (MLM) company in the Philippines.
Following Nutranomics CEO Tracy Gibbs' visit to UNO headquarters and his subsequent speaking engagement at the UNO Regional Convention held in December 2013 in Manila, UNO directors William Barbo, Oliver Chua, and Herbie Chua visited the corporate offices of Nutranomics in Draper, Utah, to meet with Dr. Gibbs and the rest of the Nutranomics team. Discussions held at these meetings led to a signed purchase order for a total of 20,000 bottles of a newly developed enzyme supplement and solidified plans for additional product development.
Mr. William Barbo of UNO stated, "UNO is the undisputed leading multi-level marketing firm in the Philippines. In order to maintain that leadership position and to be globally competitive, we standardize many business procedures and partnering with Nutranomics for new product development is one of the ways we accomplish this at UNO. This is the main reason why UNO remains to be the only ISO certified MLM company in the Philippines over these many years. UNO is pleased to be working with Dr. Gibbs and we know his products will boost our exceptional product line-up significantly."
"At UNO, there are no special trade secrets, we just combine having superior products while making them more affordable in the market," added Oliver Chua.
UNO International Corp. is the largest Philippines-based company engaged in the direct and multi-level distribution of health enhancing natural products and other services. As one of the pioneers and trend setters in MLM over the last 8 years, UNO utilizes a dynamic reward system and enhanced marketing plan designed to increase competitiveness among distributors powered by a more attractive compensation program. UNO has nearly 500,000 independent distributors all over the globe. UNO currently operates in Hong Kong, Macau, Singapore, United Arab Emirates, and Kingdom of Saudi Arabia. UNO is positioned to strengthen its international reach with new offices planned to be opened soon in the United States, United Kingdom, and Nigeria.
Dr. Gibbs concluded, "I am confident that we will be able to build and maintain a long term relationship with UNO as they expand into other countries around the world. With Nutranomics' strength in R&D and UNO's obvious strengths in direct and multi-level distribution, we can all greatly benefit from this collaboration."
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia. Learn more about Nutranomics at www.nutranomics.com.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org, or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
©2012 PR Newswire. All Rights Reserved.